Correlation Between Principal and Loncar Cancer

Can any of the company-specific risk be diversified away by investing in both Principal and Loncar Cancer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Principal and Loncar Cancer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Principal and Loncar Cancer Immunotherapy, you can compare the effects of market volatilities on Principal and Loncar Cancer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Principal with a short position of Loncar Cancer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Principal and Loncar Cancer.

Diversification Opportunities for Principal and Loncar Cancer

0.0

Correlation Coefficient

Principal  Loncar Cancer

Pay attention - limited upside

The 3 months correlation between Principal and Loncar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Principal and Loncar Cancer Immunotherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Loncar Cancer Immuno and Principal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Principal are associated (or correlated) with Loncar Cancer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Loncar Cancer Immuno has no effect on the direction of Principal i.e., Principal and Loncar Cancer go up and down completely randomly.

Pair Corralation between Principal and Loncar Cancer

If you would invest (100.00) in Principal on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Principal or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Principal  vs.  Loncar Cancer Immunotherapy

Principal

Risk-Adjusted Performance

Very Weak

Over the last 90 days Principal has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Principal is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Loncar Cancer Immuno

Risk-Adjusted Performance

Very Weak

Over the last 90 days Loncar Cancer Immunotherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Etf's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the ETF retail investors.

Pair Trading with Principal and Loncar Cancer

The main advantage of trading using opposite Principal and Loncar Cancer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Principal position performs unexpectedly, Loncar Cancer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loncar Cancer will offset losses from the drop in Loncar Cancer's long position.

The idea behind Principal and Loncar Cancer Immunotherapy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.